HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.

Abstract
Deregulation of signaling pathways is a hallmark of malignant transformation. Signaling-associated phosphoproteins can be degraded to generate cancer-specific phosphopeptides that are presented by major histocompatibility complex (MHC) class I and II molecules and recognized by T cells; however, the contribution of these phosphoprotein-specific T cells to immune surveillance is unclear. We identified 95 phosphopeptides presented on the surface of primary hematological tumors and normal tissues, including 61 that were tumor-specific. Phosphopeptides were more prevalent on more aggressive and malignant samples. CD8(+) T cell lines specific for these phosphopeptides recognized and killed both leukemia cell lines and human leukocyte antigen-matched primary leukemia cells ex vivo. Notably, healthy individuals showed robust CD8(+) T cell responses against many of these phosphopeptides within the circulating memory compartment. This immunity was significantly reduced or absent in some leukemia patients. This reduction correlated with clinical outcome; however, immunity was restored after allogeneic stem cell transplantation. These results suggest that phosphopeptides may be targets of cancer immune surveillance in humans, and point to their importance for development of vaccine-based and T cell adoptive transfer immunotherapies.
AuthorsMark Cobbold, Hugo De La Peña, Andrew Norris, Joy M Polefrone, Jie Qian, Ann Michelle English, Kara L Cummings, Sarah Penny, James E Turner, Jennifer Cottine, Jennifer G Abelin, Stacy A Malaker, Angela L Zarling, Hsing-Wen Huang, Oliver Goodyear, Sylvie D Freeman, Jeffrey Shabanowitz, Guy Pratt, Charles Craddock, Michael E Williams, Donald F Hunt, Victor H Engelhard
JournalScience translational medicine (Sci Transl Med) Vol. 5 Issue 203 Pg. 203ra125 (Sep 18 2013) ISSN: 1946-6242 [Electronic] United States
PMID24048523 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Phosphopeptides
Topics
  • CD8-Positive T-Lymphocytes (immunology)
  • Cells, Cultured
  • Humans
  • Immunity (immunology)
  • Leukemia (immunology)
  • Major Histocompatibility Complex
  • Phosphopeptides (immunology)
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: